Purchases and Sales Made in Q4 2023 in Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY) during Q4 2023. The information is specifically focused on institutions that hold shares of ALNYLAM PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-36.1K- 13.59% |
$5.47M - $7.1M
|
230K
$54.2M
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-36.1K- 10.25% |
$5.47M - $7.1M
|
316K
$74.6M
|
|
Feb 09, 2024
Q4 2023
|
Mitsubishi Ufj Trust & Banking Corp
Tokyo, M0 |
SELL
|
- |
-37.6K- 9.71% |
$5.69M - $7.38M
|
349K
$82.4M
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-38.4K- 51.27% |
$5.82M - $7.56M
|
36.5K
$8.62M
|
|
Feb 14, 2024
Q4 2023
|
Lmr Partners LLP
London, X0 |
SELL
|
- |
-39.5K- 58.36% |
$5.98M - $7.77M
|
28.2K
$6.65M
|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-39.7K- 18.34% |
$6.01M - $7.81M
|
177K
$41.7M
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-40.2K- 95.36% |
$6.08M - $7.89M
|
1.95K
$461K
|
|
Feb 14, 2024
Q4 2023
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-42.8K- 2.54% |
$6.48M - $8.41M
|
1.64M
$387M
|
|
Feb 14, 2024
Q4 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-44.5K- 15.92% |
$6.74M - $8.75M
|
235K
$55.4M
|
|
Feb 01, 2024
Q4 2023
|
California Public Employees Retirement System
Sacramento, CA |
SELL
|
- |
-48.5K- 21.29% |
$7.34M - $9.53M
|
179K
$42.3M
|
|
Feb 14, 2024
Q4 2023
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-50K- 21.28% |
$7.57M - $9.83M
|
185K
$43.7M
|
|
Feb 14, 2024
Q4 2023
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-70K- 45.41% |
$10.6M - $13.8M
|
84.1K
$19.8M
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-70.7K- 2.29% |
$10.7M - $13.9M
|
3.02M
$712M
|
|
Feb 15, 2024
Q4 2023
|
Dodge & Cox
San Francisco, CA |
SELL
|
- |
-72.8K- 1.94% |
$11M - $14.3M
|
3.67M
$867M
|
|
Jan 25, 2024
Q4 2023
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-78K- 99.97% |
$11.8M - $15.3M
|
25
$5.9K
|
|
Feb 14, 2024
Q4 2023
|
Candriam S.C.A.
|
SELL
|
- |
-78.5K- 23.87% |
$11.9M - $15.4M
|
250K
$59.1M
|
|
Feb 01, 2024
Q4 2023
|
Handelsbanken Fonder Ab
|
SELL
|
- |
-94.8K- 55.88% |
$14.4M - $18.6M
|
74.9K
$17.7M
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-109K- 53.19% |
$16.4M - $21.3M
|
95.5K
$22.5M
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-162K- 86.19% |
$24.6M - $31.9M
|
26K
$6.14M
|
|
Feb 14, 2024
Q4 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-329K- 46.52% |
$49.7M - $64.6M
|
378K
$89.1M
|
|
Feb 13, 2024
Q4 2023
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-355K- 2.15% |
$53.7M - $69.7M
|
16.2M
$3.82B
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-403K- 33.31% |
$61M - $79.2M
|
807K
$190M
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-441K- 11.24% |
$66.8M - $86.7M
|
3.48M
$822M
|
|
Feb 08, 2024
Q4 2023
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-576K- 83.69% |
$87.2M - $113M
|
112K
$26.5M
|
|
Jan 26, 2024
Q4 2023
|
Baillie Gifford & CO
|
SELL
|
- |
-1.2M- 14.65% |
$181M - $235M
|
6.97M
$1.64B
|